19,994
Views
45
CrossRef citations to date
0
Altmetric
Reviews

An overview application of silver nanoparticles in inhibition of herpes simplex virus

, , , , , , , , , & show all
Pages 263-267 | Received 04 Oct 2016, Accepted 09 Mar 2017, Published online: 12 Apr 2017

Figures & data

Figure 1. Representation of the nucleation and growth mechanisms for AgNP obtained by the citrate method according to Ref. [Citation14].

Figure 1. Representation of the nucleation and growth mechanisms for AgNP obtained by the citrate method according to Ref. [Citation14].

Figure 2. Mechanism of antiviral effect of AgNPs on different stages of virus replication: (1) interaction with viral surface, (2) interference with viral attachment, (3) inhibition of virus penetration into the cell, (4) interaction with viral genome, (5) inhibition of genome replication, (6) inhibition of protein synthesis, and (7) inhibition of assembly and release of virions.

Figure 2. Mechanism of antiviral effect of AgNPs on different stages of virus replication: (1) interaction with viral surface, (2) interference with viral attachment, (3) inhibition of virus penetration into the cell, (4) interaction with viral genome, (5) inhibition of genome replication, (6) inhibition of protein synthesis, and (7) inhibition of assembly and release of virions.

Figure 3. Antiviral properties of AgNPs.

Figure 3. Antiviral properties of AgNPs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.